DROXIA 6336 DROXIA 6336 Pill - purple capsule/oblong, 19mm

Generic Name: hydroxyurea

Pill with imprint DROXIA 6336 DROXIA 6336 is Purple, Capsule/Oblong and has been identified as Droxia 300 mg. It is supplied by Bristol-Myers Squibb.

Droxia is used in the treatment of Sickle Cell Anemia and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Droxia 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for DROXIA 6336 DROXIA 6336

Droxia

Generic Name: hydroxyurea
Imprint: DROXIA 6336 DROXIA 6336
Strength: 300 mg
Color: Purple
Size: 19.00 mm
Shape: Capsule/Oblong
Availability: Prescription only
Drug Class: Antimetabolites
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: Bristol-Myers Squibb
National Drug Code (NDC): 00003-6336
Inactive Ingredients: citric acid monohydrate, gelatin, magnesium stearate, sodium phosphate, titanium dioxide, D&C Red No. 28, D&C Red No. 33, FD&C Blue No. 1
Note: Inactive ingredients may vary.